Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 258 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2923 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
13 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-DOXAZOSIN | 2MG | TABLET | Resolved | 2020-10-08 | 2020-11-19 | 126032 |
| TEVA-DOXAZOSIN | 4MG | TABLET | Resolved | 2022-01-07 | 2022-01-13 | 152414 |
| TEVA-DOXAZOSIN | 1MG | TABLET | Resolved | 2022-12-01 | 2023-04-28 | 176857 |
| TEVA-DOXAZOSIN | 4MG | TABLET | Resolved | 2023-01-12 | 2023-02-16 | 180903 |
| TEVA-DOXAZOSIN | 2MG | TABLET | Resolved | 2023-02-02 | 2023-04-28 | 183367 |
| TEVA-DOXAZOSIN | 4MG | TABLET | Resolved | 2023-08-17 | 2023-10-04 | 202249 |
| TEVA-DOXAZOSIN | 4MG | TABLET | Resolved | 2024-03-07 | 2024-04-18 | 221543 |
| TEVA-DOXAZOSIN | 1MG | TABLET | Resolved | 2024-09-05 | 2025-02-03 | 236805 |
| TEVA-DOXAZOSIN | 1MG | TABLET | Resolved | 2025-05-30 | 2025-07-18 | 258999 |
| TEVA-DOXAZOSIN | 2MG | TABLET | Resolved | 2025-05-30 | 2025-07-18 | 259008 |
| TEVA-DOXAZOSIN | 2MG | TABLET | Actual shortage | 2025-10-16 | 2025-11-27 | 269684 |
| TEVA-DOXYCYCLINE | 100MG | CAPSULE | Resolved | 2017-08-01 | 2017-09-19 | 17881 |
| TEVA-DOXYCYCLINE | 100MG | CAPSULE | Resolved | 2017-08-01 | 2017-09-19 | 17884 |
| TEVA-DOXYCYCLINE | 100MG | TABLET | Resolved | 2019-06-27 | 2019-08-16 | 87705 |
| TEVA-DOXYCYCLINE | 100MG | TABLET | Resolved | 2019-11-07 | 2020-01-30 | 98182 |
| TEVA-DOXYCYCLINE | 100MG | CAPSULE | Resolved | 2020-02-07 | 2020-03-05 | 105573 |
| TEVA-DOXYCYCLINE | 100MG | CAPSULE | Resolved | 2020-03-26 | 2020-05-08 | 109618 |
| TEVA-DOXYCYCLINE | 100MG | TABLET | Resolved | 2020-04-23 | 2020-06-04 | 113022 |
| TEVA-DOXYCYCLINE | 100MG | CAPSULE | Resolved | 2021-03-18 | 2021-04-08 | 135961 |
| TEVA-DOXYCYCLINE | 100MG | CAPSULE | Resolved | 2021-09-02 | 2021-09-09 | 145109 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TRIAMTERENE/HCTZ | 25MG 50MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14060 |
| TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115091 |
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65017 |
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
| TEVA-TRYPTOPHAN | 500MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258565 |
| TEVA-TRYPTOPHAN | 1G | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258616 |
| TEVA-TRYPTOPHAN | 500MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258619 |
| TEVA-TRYPTOPHAN | 500MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260534 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258577 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258768 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258783 |
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256146 |
| TEVA-VALSARTAN | 80MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256149 |
| TEVA-VALSARTAN | 160MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256152 |
| TEVA-VALSARTAN | 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256155 |
| TEVA-VALSARTAN | 320MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258484 |
| TEVA-VALSARTAN | 160MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258490 |
| TEVA-VALSARTAN | 80MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258496 |